Korean Circulation Journal

  • 제54권8호
  • /
  • Pages.454-465
  • /
  • 2024
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Clinical Outcomes After Drug-Coated Balloon Treatment in Popliteal Artery Disease: K-POP Registry 12-Month Results

  • Jong-Il Park (Division of Cardiology, Yeungnam University Medical Center, Yeungnam University College of Medicine) ;
  • Young-Guk Ko (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Seung-Jun Lee (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Chul-Min Ahn (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Seung-Woon Rha (Division of Cardiology, Korea University Guro Hospital) ;
  • Cheol-Woong Yu (Division of Cardiology, Korea University Anam Hospital) ;
  • Jong Kwan Park (Division of Cardiology, National Health Insurance Service Ilsan Hospital) ;
  • Sang-Ho Park (Division of Cardiology, Soonchunhyang University Cheonan Hospital) ;
  • Jae-Hwan Lee (Division of Cardiology, Chungnam National University Sejong Hospital) ;
  • Su-Hong Kim (Division of Cardiology, Busan Veterans Hospital) ;
  • Yong-Joon Lee (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Sung-Jin Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Jung-Sun Kim (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Byeong-Keuk Kim (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Myeong-Ki Hong (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine) ;
  • Donghoon Choi (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
  • 투고 : 2024.01.03
  • 심사 : 2024.04.04
  • 발행 : 2024.08.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background and Objectives: The popliteal artery is generally regarded as a "no-stent zone." Limited data are available on the outcomes of drug-coated balloons (DCBs) for popliteal artery disease. This study aimed to evaluate the 12-month clinical outcomes among patients who received DCB treatment for atherosclerotic popliteal artery disease. Methods: This prospective, multicenter registry study enrolled 100 patients from 7 Korean endovascular centers who underwent endovascular therapy using IN.PACT DCB (Medtronic) for symptomatic atherosclerotic popliteal artery disease. The primary endpoint was 12-month clinical primary patency and the secondary endpoint was clinically driven target lesion revascularization (TLR)-free rate. Results: The mean age of the study cohort was 65.7±10.8 years, and 77% of enrolled patients were men. The mean lesion length was 93.7±53.7 mm, and total occlusions were present in 45% of patients. Technical success was achieved in all patients. Combined atherectomy was performed in 17% and provisional stenting was required in 11%. Out of the enrolled patients, 91 patients completed the 12-month follow-up. Clinical primary patency and TLR-free survival rates at 12 months were 76.0% and 87.2%, respectively. A multivariate Cox regression analysis identified female and longer lesion length as the significant independent predictors of loss of patency. Conclusions: DCB treatment yielded favorable 12-month clinical primary patency and TLR-free survival outcomes in patients with popliteal artery disease.

키워드

과제정보

This study was supported by grants from Medtronic (Santa Rosa, CA, USA); the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) (No. HI20C1566) and the Bio & Medical Technology Development Program of the National Research Foundation & MSIT (No.2020M3A9I4038455); the PatientCentered Clinical Research Coordinating Center (PACEN), funded by the Ministry of Health & Welfare, Republic of Korea (HC20C0081); and the Korea Medical Device Development Fund, funded by the Korean government (202011B29-03, 202011D12-02) and the Cardiovascular Research Center (Seoul, Korea).

참고문헌

  1. Kroger K, Santosa F, Goyen M. Biomechanical incompatibility of popliteal stent placement. J Endovasc Ther 2004;11:686-94. https://doi.org/10.1583/04-127.1
  2. Hoffmann U, Vetter J, Rainoni L, Leu AJ, Bollinger A. Popliteal artery compression and force of active plantar flexion in young healthy volunteers. J Vasc Surg 1997;26:281-7. https://doi.org/10.1016/S0741-5214(97)70190-3
  3. Tamashiro GA, Tamashiro A, Villegas MO, et al. Flexions of the popliteal artery: technical considerations of femoropopliteal stenting. J Invasive Cardiol 2011;23:431-3.
  4. Poulson W, Kamenskiy A, Seas A, Deegan P, Lomneth C, MacTaggart J. Limb flexion-induced axial compression and bending in human femoropopliteal artery segments. J Vasc Surg 2018;67:607-13. https://doi.org/10.1016/j.jvs.2017.01.071
  5. Gokgol C, Diehm N, Kara L, Buchler P. Quantification of popliteal artery deformation during leg flexion in subjects with peripheral artery disease: a pilot study. J Endovasc Ther 2013;20:828-35. https://doi.org/10.1583/13-4332MR.1
  6. Tosaka A, Soga Y, Iida O, et al. Classification and clinical impact of restenosis after femoropopliteal stenting. J Am Coll Cardiol 2012;59:16-23. https://doi.org/10.1016/j.jacc.2011.09.036
  7. Tepe G, Laird J, Schneider P, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial. Circulation 2015;131:495-502. https://doi.org/10.1161/CIRCULATIONAHA.114.011004
  8. Giacoppo D, Cassese S, Harada Y, et al. Drug-coated balloon versus plain balloon angioplasty for the treatment of femoropopliteal artery disease: an updated systematic review and meta-analysis of randomized clinical trials. JACC Cardiovasc Interv 2016;9:1731-42. https://doi.org/10.1016/j.jcin.2016.06.008
  9. Caradu C, Lakhlifi E, Colacchio EC, et al. Systematic review and updated meta-analysis of the use of drugcoated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease. J Vasc Surg 2019;70:981-995.e10. https://doi.org/10.1016/j.jvs.2019.01.080
  10. Cha JJ, Lee JH, Ko YG, et al. Clinical outcomes of atherectomy plus drug-coated balloon versus drug-coated balloon alone in the treatment of femoropopliteal artery disease. Korean Circ J 2022;52:123-33. https://doi.org/10.4070/kcj.2021.0246
  11. Cummings P, Rivara FP, Koepsell TD. Writing informative abstracts for journal articles. Arch Pediatr Adolesc Med 2004;158:1086-8. https://doi.org/10.1001/archpedi.158.11.1086
  12. Rastan A, Krankenberg H, Baumgartner I, et al. Stent placement versus balloon angioplasty for the treatment of obstructive lesions of the popliteal artery: a prospective, multicenter, randomized trial. Circulation 2013;127:2535-41. https://doi.org/10.1161/CIRCULATIONAHA.113.001849
  13. San Norberto EM, Flota CM, Fidalgo-Domingos L, Taylor JH, Vaquero C. Real-world results of Supera stent implantation for popliteal artery atherosclerotic lesions: 3-year outcome. Ann Vasc Surg 2020;62:397-405. https://doi.org/10.1016/j.avsg.2019.06.038
  14. Scheinert D, Werner M, Scheinert S, et al. Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry. JACC Cardiovasc Interv 2013;6:65-71. https://doi.org/10.1016/j.jcin.2012.09.011
  15. Goltz JP, Ritter CO, Kellersmann R, Klein D, Hahn D, Kickuth R. Endovascular treatment of popliteal artery segments P1 and P2 in patients with critical limb ischemia: initial experience using a helical nitinol stent with increased radial force. J Endovasc Ther 2012;19:450-6. https://doi.org/10.1583/11-3591MR.1
  16. Wu X, Peng Z, Qin J, Yang X, Lu X, Ye K. Outcomes of drug-coated balloon angioplasty for isolated chronic occlusion of the popliteal artery: a retrospective single-institution study. J Vasc Interv Radiol 2021;32:593-601. https://doi.org/10.1016/j.jvir.2020.12.024
  17. Torsello G, Stavroulakis K, Brodmann M, et al. Three-year sustained clinical efficacy of drug-coated balloon angioplasty in a real-world femoropopliteal cohort. J Endovasc Ther 2020;27:693-705. https://doi.org/10.1177/1526602820931477
  18. Stavroulakis K, Schwindt A, Torsello G, et al. Directional atherectomy with antirestenotic therapy vs drug-coated balloon angioplasty alone for isolated popliteal artery lesions. J Endovasc Ther 2017;24:181-8. https://doi.org/10.1177/1526602816683933
  19. Rastan A, McKinsey JF, Garcia LA, et al. One-year outcomes following directional atherectomy of popliteal artery lesions: subgroup analysis of the prospective, multicenter DEFINITIVE LE trial. J Endovasc Ther 2018;25:100-8. https://doi.org/10.1177/1526602817740133
  20. McKinsey JF, Zeller T, Rocha-Singh KJ, Jaff MR, Garcia LA; DEFINITIVE LE Investigators. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE study. JACC Cardiovasc Interv 2014;7:923-33. https://doi.org/10.1016/j.jcin.2014.05.006
  21. Spiliopoulos S, Kitrou P, Galanakis N, et al. Incidence and endovascular treatment of isolated atherosclerotic popliteal artery disease: outcomes from the IPAD multicenter study. Cardiovasc Intervent Radiol 2018;41:1481-7. https://doi.org/10.1007/s00270-018-2028-7
  22. Kohi MP, Brodmann M, Zeller T, et al. Sex-related differences in the long-term outcomes of patients with femoropopliteal arterial disease treated with the IN.PACT drug-coated balloon in the IN.PACT SFA randomized controlled trial: a post hoc analysis. J Vasc Interv Radiol 2020;31:1410-1418.e10. https://doi.org/10.1016/j.jvir.2020.05.012